4//SEC Filing
Dube Eric M 4
Accession 0001415889-25-003820
CIK 0001438533other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 9:23 PM ET
Size
5.0 KB
Accession
0001415889-25-003820
Insider Transaction Report
Form 4
Dube Eric M
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Sale
Common Stock
2025-02-11$24.04/sh−11,375$273,455→ 419,173 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001763494
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 9:23 PM ET
- Size
- 5.0 KB